Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction

Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction

Clinical genetics in paediatric practice bridges molecular biology and bedside patient care. A systematic understanding of inheritance patterns allows the clinician to determine disease etiology, calculate precise recurrence risks, guide genomic diagnostic workflows, and deliver structured genetic counselling. While classic Mendelian principles explain thousands of monogenic conditions, a substantial proportion of paediatric genetic pathology is governed by non-Mendelian mechanisms—including genomic imprinting, mitochondrial heteroplasmy, trinucleotide repeat expansions, and somatic or germline mosaicism.

---

Mendelian Inheritance Patterns

Mendelian disorders arise from pathogenic variants in single nuclear genes. The phenotypic transmission pattern is determined by whether the gene resides on an autosome (chromosomes 1–22) or a sex chromosome (X or Y), and whether a single mutant allele (dominant) or both mutant alleles (recessive) are necessary to produce clinical disease.

                               [Mendelian Inheritance]
                                          |
                  +-----------------------+-----------------------+
                  |                                               |
            [Autosomal]                                      [X-Linked]
                  |                                               |
         +--------+--------+                             +--------+--------+
         |                 |                             |                 |
    [Dominant]        [Recessive]                   [Recessive]       [Dominant]
  - 50% recurrence   - 25% recurrence              - No male-to-     - Affected father:
  - Vertical          - Horizontal                   male transfer     100% daughters
  - Incomplete        - Consanguinity               - Carrier mother:  - Lethal in many
    penetrance          amplification                 50% sons ill      males (IP)

1. Autosomal Dominant (AD) Inheritance

In autosomal dominant disorders, heterozygosity for a single pathogenic variant is sufficient to manifest the clinical phenotype. Key epidemiological and biological principles include:

• Transmission and Recurrence Risk: An affected individual has a $50\%$ ($1 \text{ in } 2$) probability of transmitting the mutant allele to each offspring, irrespective of fetal sex. Transmission occurs in a vertical pattern across successive generations without skipping, provided penetrance is complete.
• Variable Expressivity: The severity and spectrum of clinical symptoms differ markedly among individuals harboring the identical pathogenic variant, even within the same biological pedigree. In Neurofibromatosis type 1 (NF1), an affected parent may exhibit only mild cutaneous manifestations (e.g., multiple café-au-lait macules and axillary freckling), while their child inherits the exact same pathogenic variant yet develops plexiform neurofibromas, optic pathway gliomas, and tibial pseudarthrosis.
• Incomplete (Reduced) Penetrance: The statistical proportion of individuals carrying a specific disease-associated genotype who actually manifest any detectable clinical features of the disorder. A condition with $80\%$ penetrance means that $20\%$ of mutation carriers will remain clinically asymptomatic throughout life, creating apparent "generation skipping" on a pedigree. Non-penetrant carriers nonetheless retain a $50\%$ risk of transmitting the variant to their children.
• Pleiotropy: A single mutant gene produces diverse, seemingly unrelated structural anomalies across multiple organ systems. In Marfan syndrome (FBN1 mutations encoding fibrillin-1), a single molecular defect causes ectopia lentis (ocular), aortic root aneurysm and dissection (cardiovascular), and tall stature, pectus deformities, and arachnodactyly (skeletal).
• De Novo Mutations and Advanced Paternal Age: A significant fraction of severe AD disorders present in children with completely healthy, non-carrier parents due to a new spontaneous mutation (de novo) arising during gametogenesis. Advanced paternal age (typically $>40$ years) is strongly associated with an increased rate of de novo point mutations, particularly in the FGFR3 gene (causing Achondroplasia) and the FGFR2 gene (causing Apert syndrome). This paternal age effect reflects the cumulative rounds of mitotic DNA replication that male spermatogonial stem cells undergo continuously throughout life (over 600 replications by age 40, compared to only 23 mitotic divisions in female oogenesis, which ceases embryonically).
• Germline (Gonadal) Mosaicism: An unaffected parent harbors a pathogenic mutation restricted to a clonal subpopulation of germ cells (sperm or oocytes) without somatic tissue involvement. Although the parent tests negative on standard peripheral blood DNA analysis and displays zero clinical signs, they can transmit the mutation to multiple offspring. Germline mosaicism must be suspected when clinically normal parents have two or more children affected by an apparently de novo autosomal dominant disorder, such as COL1A1/COL1A2-related osteogenesis imperfecta, or an X-linked disorder such as Duchenne muscular dystrophy.

2. Autosomal Recessive (AR) Inheritance

Autosomal recessive diseases require the presence of pathogenic variants on both homologous alleles (homozygosity or compound heterozygosity). Features include:

• Recurrence Risks and Carrier Segregation: When both parents are asymptomatic heterozygous carriers ($Aa \times Aa$): $\text{Affected Child } (aa) = 25\% \quad (1 \text{ in } 4)$ $\text{Asymptomatic Carrier Child } (Aa) = 50\% \quad (2 \text{ in } 4)$ $\text{Homozygous Wild-Type Child } (AA) = 25\% \quad (1 \text{ in } 4)$
• Conditional Probability for Healthy Siblings: A critical clinical calculation frequently examined on specialty assessments: if an unaffected sibling is born to carrier parents, that sibling has excluded the $aa$ state. Therefore, among healthy surviving siblings, the probability of being an asymptomatic carrier is: $P(\text{Carrier } | \text{ Unaffected}) = \frac{2}{3} \approx 66.7\%$
• Obligate Heterozygotes: In the usual inherited AR pedigree, both parents of an affected child are carriers. All children of an affected ($aa$) individual are carriers if the other parent is neither affected nor a carrier; a carrier partner instead gives a 50% risk of affected offspring.
• Consanguinity: Union between biological relatives who share a common ancestor increases the coefficient of inbreeding ($F$) and significantly elevates the probability that both partners have inherited the identical rare pathogenic allele from that common progenitor (identity-by-descent). Consanguinity markedly increases the incidence of rare AR metabolic disorders (e.g., inborn errors of metabolism, spinal muscular atrophy).
• Pseudodominance: When an affected individual ($aa$) partners with an unaffected heterozygous carrier ($Aa$) of the same condition, the offspring have a $50\%$ risk of being affected ($aa$) and a $50\%$ risk of being carriers ($Aa$). This vertical transmission in consecutive generations mimics an autosomal dominant pedigree, occurring frequently in conditions with high carrier frequencies in specific populations (e.g., Cystic Fibrosis [CFTR] in Northern Europeans, Sickle Cell Anemia [HBB] in sub-Saharan African populations).

3. X-Linked Recessive (XLR) Inheritance

X-linked recessive conditions are caused by mutations on the X chromosome and demonstrate unique sex-skewed transmission characteristics:

• Transmission Mechanics: Heterozygous females ($X^A X^a$) act as asymptomatic or mildly symptomatic carriers. An affected male ($X^a Y$) is hemizygous because he possesses only one X chromosome. Consequently:
  • An affected father transmits the mutant X chromosome to 100% of his daughters (making all daughters obligate carriers) and transmits his Y chromosome to 100% of his sons (no male-to-male transmission).
  • A carrier mother transmits the mutant allele to $50\%$ of her sons (who will be affected) and $50\%$ of her daughters (who will be carriers).
• Lyonization and Manifesting Female Carriers: According to the Lyon hypothesis, one of the two X chromosomes in each somatic female cell undergoes random, permanent epigenetic transcriptional inactivation (forming a Barr body) during early blastocyst development. In rare instances, skewed (non-random) X-inactivation preferentially silences the normal wild-type X chromosome in critical target tissues, resulting in a manifesting female carrier who displays clinical features of an XLR disease (e.g., elevated creatine kinase and muscle weakness in female DMD carriers, or spontaneous bleeding in female Hemophilia A [F8] carriers). Manifestation in females also occurs in monosomy X (Turner syndrome, 45,X) or when an X-autosome balanced translocation disrupts the disease gene on the active X chromosome.

4. X-Linked Dominant (XLD) Inheritance

In XLD conditions, a single mutant allele on the X chromosome produces disease in both females and males:

• Pedigree Patterns: An affected father transmits the condition to 100% of his daughters and 0% of his sons. An affected heterozygous mother transmits the condition to $50\%$ of her offspring regardless of fetal sex.
• Male Lethality: Because hemizygous males lack a second normal X chromosome, many X-linked dominant disorders are embryonically lethal in males, manifesting clinically as pedigrees containing only affected females, a deficit of liveborn males, and a high frequency of spontaneous first-trimester miscarriages. A classic example is Incontinentia Pigmenti (IKBKG variants). Severe MECP2 variants in males usually cause neonatal encephalopathy, often with early postnatal death.
• Non-Lethal XLD Conditions: Sex-related severity depends on the condition. X-linked hypophosphatemic rickets (PHEX) generally affects males and females similarly, whereas males with Fragile X syndrome are usually more severely affected than females.

---

Non-Mendelian Mechanisms

Many paediatric genetic disorders defy classical Mendelian transmission rules. Clinicians must recognize these distinct molecular mechanisms to prevent erroneous recurrence risk estimation.

                              [Non-Mendelian Mechanisms]
                                          |
     +------------------+-----------------+------------------+------------------+
     |                  |                                    |                  |
[Genomic Imprinting] [Mitochondrial Inheritance]     [Dynamic Expansions]   [Mosaicism]
 - Monoallelic parent- - Maternal transmission to all - Genetic anticipation - Somatic (patchy)
   of-origin silencing - Heteroplasmy threshold       - FMR1 (CGG)           - Germline (risk to
 - PWS vs Angelman     - High-energy organ damage     - DMPK (CTG)             multiple offspring)

1. Genomic Imprinting and Uniparental Disomy (UPD)

Genomic imprinting is an epigenetic process whereby specific genes are monoallelically silenced (transcriptionally inactivated) in a parent-of-origin-specific manner, mediated by allele-specific DNA methylation and histone modifications established during gametogenesis.

The 15q11-q13 Paradigm: Prader-Willi and Angelman Syndromes

The critical region on chromosome 15q11-q13 contains both maternally and paternally imprinted genes:

• Prader-Willi Syndrome (PWS): Arises from the loss of paternally expressed genes (SNRPN, snoRNAs, MAGEL2) in the 15q11-q13 region, because the homologous maternal alleles are normally epigenetically silenced.
  • Molecular Mechanisms: Paternal 15q11-q13 microdeletion (~$70\%$ of cases; recurrence risk $<1\%$); Maternal Uniparental Disomy (maternal UPD 15, where the child inherits both chromosomes 15 from the mother and none from the father, ~25–$28\%$ of cases; recurrence risk $<1\%$); Imprinting center mutations (~2–$3\%$; recurrence risk up to $50\%$ if father carries defect).
  • Clinical Features: Severe neonatal hypotonia with poor suck and failure to thrive in infancy; followed in early childhood by hyperphagia and lack of satiety leading to rapid morbid obesity; hypogonadism (cryptorchidism, micropenis); dysmorphic almond-shaped palpebral fissures, narrow bifrontal diameter; developmental delay and intellectual impairment.
• Angelman Syndrome (AS): Arises from the loss of maternal expression of the UBE3A gene (ubiquitin-protein ligase E3A) in neurons, where the paternal UBE3A allele is normally silenced by an antisense transcript.
  • Molecular Mechanisms: Maternal 15q11-q13 microdeletion ($70\%$); Paternal Uniparental Disomy (paternal UPD 15, inheriting both copies from father, 5–$7\%$); UBE3A point mutations ($10\%$, carries a $50\%$ recurrence risk if mother carries mutation); Imprinting center defect ($3\%$).
  • Clinical Features: Severe intellectual disability with absent or minimal functional speech; paroxysmal outbursts of inappropriate laughter with a happy demeanor ("happy puppet"); severe ataxia and jerky uncoordinated limb tremors; microcephaly and early-onset refractory seizures.
• Diagnostic Testing for Imprinting Disorders: The initial diagnostic test of choice is methylation-specific PCR (MS-PCR) or Methylation-Specific Multiplex Ligation-dependent Probe Amplification (MS-MLPA) at 15q11-q13, which detects abnormal parent-specific methylation in $>99\%$ of PWS and $\sim 80\%$ of AS cases, with copy-number analysis to detect deletions and parent–child polymorphism testing to establish UPD where necessary. SNP arrays detect isodisomy but may miss heterodisomy; methylation and parental studies distinguish the remaining mechanisms.

2. Mitochondrial (Maternal) Inheritance

Mitochondrial DNA (mtDNA) is a circular double-stranded molecule encoding 37 genes essential for oxidative phosphorylation. Because mammalian sperm contribute virtually no mitochondria to the zygote, mtDNA is transmitted exclusively through maternal oocytes.

• Transmission Principles: An affected or heteroplasmic mother transmits mutated mtDNA to 100% of her biological children (both sons and daughters). An affected male never transmits the condition to any of his offspring.
• Heteroplasmy: Each eukaryotic cell contains hundreds of mitochondria and thousands of individual mtDNA genomes. Heteroplasmy refers to the intracellular coexistence of mutated and wild-type mtDNA copies. In contrast, homoplasmy refers to a uniform population of either all-mutant or all-wild-type mtDNA.
• Threshold Effect: Clinical biochemical dysfunction and clinical symptoms manifest only when the percentage of mutant mtDNA genomes within a specific tissue exceeds a critical energetic threshold (typically $60\%$ to $90\%$). Tissues with the highest baseline metabolic and oxidative demands—the central nervous system, skeletal muscle, cardiac myocardium, retina, and cochlea—are preferentially vulnerable.
• Replicative Segregation and Variable Expressivity: During mitotic and meiotic cell divisions, mitochondria replicate independently and partition randomly between daughter cells. This random drift alters the heteroplasmy percentage significantly between siblings born to the same mother, producing dramatic intra-familial phenotypic variability ranging from asymptomatic to fatal infantile encephalopathy.
• Classic Mitochondrial Disorders:
  • MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes): Characterized by recurrent stroke-like episodes before age 40 (often parietal/occipital, non-vascular territorial distribution), muscle weakness, lactic acidosis, and sensorineural hearing loss; most commonly due to the m.3243A>G mutation in MT-TL1.
  • MERRF (Myoclonic Epilepsy with Ragged Red Fibers): Characterized by progressive myoclonus, generalized epilepsy, cerebellar ataxia, and ragged-red fibers on Gomori trichrome muscle biopsy (due to subsarcolemmal mitochondrial accumulation); most commonly m.8344A>G in MT-TK.
  • Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy): Infantile-onset psychomotor regression, dystonia, brainstem dysfunction, respiratory abnormalities, and bilateral symmetrical necrotizing lesions in basal ganglia/brainstem; can arise from both mtDNA mutations and nuclear-encoded mitochondrial genes (autosomal recessive).

3. Trinucleotide Repeat Expansions (Dynamic Mutations)

Trinucleotide repeat disorders are characterized by unstable tandem microsatellite repeats that expand in length during gametogenesis and DNA replication. They are called dynamic mutations because the mutation rate and repeat length change across generations.

• Genetic Anticipation: The clinical phenomenon whereby the disorder presents at an earlier chronological age and with progressively greater phenotypic severity in successive generations of a family, directly correlating with an increasing expansion of repeat copy numbers.
• Premutation vs. Full Mutation: Individuals with repeat lengths within the premutation range do not develop the classic monogenic syndrome, but the allele is unstable and prone to massive expansion when passed through the germline.
  • Parental Sex-Specific Expansion Biases: Repeat expansion risk depends strongly on the sex of the transmitting parent:
    • Maternal Transmission Expansion: Fragile X syndrome (FMR1, CGG repeat in 5' UTR) expands from premutation (55–200 repeats) to full mutation ($>200$ repeats) almost exclusively during maternal oogenesis. Myotonic Dystrophy Type 1 (DMPK, CTG repeat in 3' UTR) expands massively during maternal oogenesis, leading to the devastating congenital myotonic dystrophy phenotype (severe neonatal hypotonia, respiratory failure, facial diplegia).
    • Paternal Transmission Expansion: Huntington disease (HTT, CAG repeat in coding region) expands predominantly during paternal spermatogenesis, frequently causing juvenile-onset Huntington disease when inherited from an affected father.
    • Friedreich Ataxia (FXN, GAA repeat in intron 1): The sole common autosomal recessive repeat expansion disorder; impairs frataxin transcription, causing progressive ataxia, loss of deep tendon reflexes, hypertrophic cardiomyopathy, and diabetes mellitus.

4. Mosaicism (Somatic vs. Germline)

Mosaicism denotes the presence of two or more genetically distinct cellular lineages within a single individual, arising from a post-zygotic de novo mutation:

• Somatic Mosaicism: The mutation occurs in a post-zygotic somatic progenitor cell. The mutant lineage populates a subsegment of body tissues, often displaying a patchy, segmental, or blaschkoid distribution (e.g., McCune-Albright syndrome due to post-zygotic GNAS activating mutations; segmental neurofibromatosis). The somatic mutation is not transmitted to offspring unless germline tissue is also colonized.
• Germline (Gonadal) Mosaicism: The mutation occurs post-zygotically in a primordial germ cell ancestor destined to form the ovaries or testes. The parent remains clinically unaffected because somatic tissues carry the wild-type genome, but a substantial fraction of their gametes harbor the pathogenic variant. Clinically, this manifests when healthy parents with normal genetic testing have two or more children with a severe autosomal dominant or X-linked disorder (e.g., Duchenne muscular dystrophy, Osteogenesis Imperfecta).

---

Standard Three-Generation Pedigree Construction

A meticulous three-generation pedigree remains the indispensable foundational diagnostic tool of clinical genetics. Pedigrees must record full medical and reproductive histories of the proband, siblings, parents, maternal and paternal aunts, uncles, cousins, and grandparents.

                       [Standard Pedigree Symbols]

    Male: square □       Female: circle ○       Sex unspecified: diamond ◇
    Affected: filled ■ / ● / ◆                 Carrier: dot inside symbol (e.g., ⊙)
    Deceased: diagonal slash through the appropriate symbol
    Proband: arrow pointing to the symbol (no death slash unless deceased)

    Partnership:    □────○        Consanguineous partnership:    □════○
                       │                                           │
                 ┌─────┴─────┐                               ┌─────┴─────┐
                 □           ○                               □           ○
               Older       Younger                         Older       Younger

    Siblings are ordered left to right by birth; generations run top to bottom.
    State the meaning of all shading in the pedigree legend.

International Pedigree Nomenclature Standards

Standardized symbols established by the National Society of Genetic Counselors (NSGC) and international dysmorphology consortia must be strictly applied:

1. Basic Sex and Status Symbols:
   • Square: Biological male.
   • Circle: Biological female.
   • Diamond: Sex unspecified or unknown (e.g., early pregnancy, unknown relative).
   • Solid Shaded / Fully Darkened: Clinically affected with the designated phenotype.
   • Unshaded (Open): Clinically unaffected.
   • Central Dot or Half-Shaded: Verified asymptomatic heterozygous carrier of an autosomal or X-linked recessive variant.
   • Diagonal Strikethrough Line (/): Deceased individual (record age and cause of death beside the symbol).
2. Relationship Lines and Unions:
   • Single Horizontal Line: Biological mating/reproductive partnership.
   • Double Horizontal Line: Consanguineous partnership (biological relationship between cousins or related individuals sharing common ancestors).
   • Vertical Line Dropping Downward: Offspring descent line connected to a horizontal sibship line.
   • Sibship Order: Siblings are drawn from left to right in chronological order of birth (oldest sibling on the far left).
3. Proband Identification:
   • The Proband (or index case) is the affected individual who first brings the family to medical genetic attention. Denoted by a bold arrow (P) pointing directly to the symbol.
   • The Consultand is the individual presenting for genetic risk assessment and counselling (may or may not be the proband).
4. Pregnancy and Reproductive Events:
   • Small Triangle: Spontaneous abortion (miscarriage); specify gestational weeks.
   • Triangle with a Diagonal Slash: Elective termination of pregnancy.
   • Square or Circle within Brackets [ ]: Adopted individual (dashed descent line indicates adoption into family; solid line indicates adoption out).
   • Diagonal Slanted Lines Arising from Single Point: Dizygotic twins (fraternal); monozygotic twins (identical) are joined by an additional horizontal connecting bar.
5. Standard Pedigree Notation:
   • Each horizontal generation is numbered with Roman numerals on the left margin (e.g., $\text{I}$, $\text{II}$, $\text{III}$), starting with the oldest known generation at the top.
   • Individuals within each generation are numbered with Arabic numerals sequentially from left to right (e.g., $\text{II-1}$, $\text{II-2}$, $\text{II-3}$).
   • Age, clinical diagnosis, age of onset, and genetic test status (e.g., "c.1521_1523delCTT / p.Phe508del heteroz") must be annotated directly below the corresponding individual symbol.